You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis
  1. Jatinder Goyal,
  2. Jodie A Barkin,
  3. Jamie S Barkin
  1. Division of Gastroenterology, University of Miami, Leonard M. Miller School of Medicine, Miami, Florida, USA
  1. Correspondence to Dr Jatinder Goyal, Division of Gastroenterology, University of Miami, Leonard M. Miller School of Medicine, 1400 NW 12th Ave, Miami, FL 33136, USA; jatinder.goyal{at}jhsmiami.org

https://doi.org/10.1136/gutjnl-2017-314460

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with great interest the article by Masamune et al 1 regarding the role of long-term maintenance corticosteroids in patients with autoimmune pancreatitis (AIP).1 AIP is a steroid responsive disorder, which has two distinct entities with overlapping features, classified as type I and type II AIP. While type I AIP is a part of a spectrum of IgG4-related disease with extrapancreatic manifestations, type II is a pancreas-specific disease. The diagnostic criteria, treatment approach and prognosis are different between the …

    View Full Text

    Footnotes

    • Contributors All authors have contributed equally to the preparation of the manuscript.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.